Why is cancer drug discovery so difficult?
- Published in:
- 2007
- By:
- Publication type:
- review
Works matching IS 14741776 AND DT 2007 AND VI 6 AND IP 2
Results: 24
1
2
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 140, doi. 10.1038/nrd2173
- By:
- Publication type:
- Article
3
Drug discovery for heart failure: a new era or the end of the pipeline?
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 127, doi. 10.1038/nrd2219
- By:
- Publication type:
- Article
4
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 149, doi. 10.1038/nrd2240
- By:
- Publication type:
- Article
5
Preclinical safety testing of monoclonal antibodies: the significance of species relevance.
- Published in:
- 2007
- By:
- Publication type:
- review
6
Benchside to business.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 167, doi. 10.1038/nrd2244
- By:
- Publication type:
- Article
7
Sitagliptin.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 109, doi. 10.1038/nrd2245
- By:
- Publication type:
- Article
8
Clinical forecasting in drug development.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 107, doi. 10.1038/nrd2246
- By:
- Publication type:
- Article
9
2006 drug approvals: finding the niche.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 99, doi. 10.1038/nrd2247
- By:
- Publication type:
- Article
10
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 102, doi. 10.1038/nrd2248
- Publication type:
- Article
11
Supreme Court sides with MedImmune.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 104, doi. 10.1038/nrd2249
- By:
- Publication type:
- Article
12
Carlo Incerti.
- Published in:
- 2007
- By:
- Publication type:
- Interview
13
Less is more.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 112, doi. 10.1038/nrd2252
- By:
- Publication type:
- Article
14
Escaping inhibition.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 111, doi. 10.1038/nrd2253
- By:
- Publication type:
- Article
15
Rat to the rescue.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 112, doi. 10.1038/nrd2254
- By:
- Publication type:
- Article
16
Ethical sourcing?
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 114, doi. 10.1038/nrd2255
- By:
- Publication type:
- Article
17
New drug lead from Madagascar's rainforests.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 113, doi. 10.1038/nrd2256
- By:
- Publication type:
- Article
18
In brief.
- Published in:
- 2007
- Publication type:
- Abstract
19
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 2, p. 95, doi. 10.1038/nrd2258
- By:
- Publication type:
- Article
20
Same old story?
- Published in:
- 2007
- Publication type:
- Editorial
21
Avoiding premature licensing.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
22
Drugs, their targets and the nature and number of drug targets.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
23
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
24
Multi-targeting by monotherapeutic antibacterials.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice